A comprehensive approach to treatment and prevention in a day hospital setting

View at publisher Summarise with VIRAT
Authors: D. Airapetov, A. Makarochkin, N. Fedyaeva
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Along with outpatient and inpatient treatment, the provision of medical care in a day hospital (DH) is becoming increasingly popular. Recently, more and more patients with functional somatic disorders, such as recurrent pain syndrome (headache, abdominal pain, or back pain), have been seeking medical attention for examination and further treatment. If left untreated, these conditions can lead to chronic pain and significantly impact the quality of life. After our survey, we found that a large number of patients with dizziness and headaches had low levels of brain-derived neurotrophic factor (BDNF). Given the significant role of the BDNF in modulating neuroplastic processes, the decrease in its level that we have identified in our patients can probably be considered a metabolic marker of the presence of neurodegenerative processes in the brain tissue of patients with dizziness and headache. Significant differences in the percentage ratio were found in patients with different levels of plasma BDNF concentration, depending on the frequency of headache episodes. Approaches to the treatment and prevention of BDNF levels in the body in recurrent headache are described. The expediency of using both drug-based and non-drug-based treatment methods in a day hospital setting is substantiated, and these methods are described in detail in the recommendations for discharge from the day hospital.

Fields of Study & Subjects

Migraine and Headache Studies Traumatic Brain Injury Research Temporomandibular Joint Disorders

Publication details

Journal / source
Vrach
Pages
57–57
Publication date
20 March 2026
Language
EN